Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
Link to record
Permanent link

Direct link
Publications (10 of 36) Show all publications
Sjöstedt, H., Wellhagen, A., Hvarfner, A., Bjurling-Sjöberg, P., Hintze, C., Warnberg, M. G., . . . Schell, C. O. (2026). Using inability to walk to predict in-hospital mortality in a high-income country - A comparison with the National Early Warning Score in a multicenter prospective cohort. Journal of critical care, 94, Article ID 155598.
Open this publication in new window or tab >>Using inability to walk to predict in-hospital mortality in a high-income country - A comparison with the National Early Warning Score in a multicenter prospective cohort
Show others...
2026 (English)In: Journal of critical care, ISSN 0883-9441, E-ISSN 1557-8615, Vol. 94, article id 155598Article in journal (Refereed) Published
Abstract [en]

Background

Inability to walk (IATW) has predicted mortality in emergency units in low-income settings, but its value among inpatients in high-income countries is unknown.

Aim

To evaluate the predictive accuracy of IATW for 30-day in-hospital mortality among inpatients in a highincome country, compare its performance with NEWS CRITICAL (the threshold for urgent review), and assess whether IATW provides complementary risk stratification when combined with NEWS.

Methods

All adult inpatients in four Swedish hospitals were prospectively examined in a multicenter pointprevalence assessment. IATW was defined as inability to walk five steps without physical assistance or walking aids. NEWS was calculated from contemporaneous vital signs. The primary outcome was 30-day inhospital mortality. We computed sensitivity, specificity, predictive values, and likelihood ratios. Multivariable logistic regression assessed the association between IATW and mortality, adjusted for NEWS, age, and sex.

Results 

Of 1842 patients, 59.9% were IATW-positive and 22.3% met NEWS CRITICAL (>= 5 or any singleparameter score of 3). Mortality was 4.6%. IATW had higher sensitivity (86.9% vs 66.7%) but lower specificity (41.4% vs 79.8%) than NEWS CRITICAL; NPV was high for both (98.5% vs 98.0%). IATW was independently associated with mortality after adjustment for NEWS (OR 2.43, 95% CI 1.24-4.76; p = 0.009). Those both IATW-negative and with NEWS <5 (35.2% of the cohort) had 1.1% mortality.

Conclusions

Inability to walk (IATW) is a bedside assessment that when negative identifies patients with low 30day in-hospital mortality and provides complementary information to NEWS. Its low complexity, high sensitivity and low negative likelihood ratios support its use in clinical risk assessments.

Place, publisher, year, edition, pages
Elsevier, 2026
Keywords
Inability to walk, In-hospital mortality, Early warning score, National Early Warning Score, Triage, Predictive accuracy, Risk stratification
National Category
Cardiology and Cardiovascular Disease Public Health, Global Health and Social Medicine
Identifiers
urn:nbn:se:uu:diva-586533 (URN)10.1016/j.jcrc.2026.155598 (DOI)001758393800001 ()42044607 (PubMedID)2-s2.0-105036534766 (Scopus ID)
Available from: 2026-05-25 Created: 2026-05-25 Last updated: 2026-06-09Bibliographically approved
Larsson, E., Valadkhani, A., Eriksson, J., Svensk, E., Hammarskjöld, F., Castegren, M., . . . Bell, M. (2026). WIse CHoices in the ICU (WICH-ICU): Protocol and Statistical Analysis Plan for a Stepped-Wedge Cluster Randomized Trial of Choosing Wisely Interventions in Swedish Intensive Care Units. Acta Anaesthesiologica Scandinavica, 70(10), Article ID e70339.
Open this publication in new window or tab >>WIse CHoices in the ICU (WICH-ICU): Protocol and Statistical Analysis Plan for a Stepped-Wedge Cluster Randomized Trial of Choosing Wisely Interventions in Swedish Intensive Care Units
Show others...
2026 (English)In: Acta Anaesthesiologica Scandinavica, ISSN 0001-5172, E-ISSN 1399-6576, Vol. 70, no 10, article id e70339Article in journal (Refereed) Published
Abstract [en]

Background

Healthcare overuse, including unnecessary diagnostic testing and procedures, contributes to patient harm, increased healthcare costs, and resource waste. The Choosing Wisely initiative aims to reduce low-value care through evidence-based recommendations. However, limited evidence exists regarding the safety and effectiveness of implementing Choosing Wisely recommendations in intensive care settings.

Methods

The WICH-ICU is a registry-based stepped-wedge cluster randomized controlled trial designed to evaluate the implementation of specific Choosing Wisely interventions in Swedish intensive care units (ICUs). The study will include adult patients treated in participating Swedish ICUs. The intervention consists of three parts of the Choosing Wisely recommendations: (1) reduced frequency of arterial blood gas sampling, (2) reduced routine laboratory testing, and (3) reduced routine chest radiography. The primary outcome is 30-day mortality. Secondary outcomes include ICU length of stay, duration of mechanical ventilation (invasive and noninvasive), continuous renal replacement therapy duration, and ICU readmission within 72 h. Intervention data, testing intensity (arterial blood gas samples, laboratory tests, and chest radiographs per patient-day), will be collected through local monitoring, while outcome data will be obtained from the Swedish Intensive Care Registry (SIR). The stepped-wedge design allows each participating ICU to serve as its own control, with randomized timing of intervention implementation.

Discussion

This study will provide evidence on the safety and effectiveness of implementing Choosing Wisely recommendations in intensive care settings. The stepped-wedge cluster randomized design minimizes contamination while allowing all participating sites to eventually receive the intervention. The results will inform evidence-based de-implementation strategies in critical care.Trial Registration ClinicalTrials.gov identifier: NCT07013175

Place, publisher, year, edition, pages
John Wiley & Sons, 2026
Keywords
Choosing Wisely, cluster randomized trial, de-implementation, healthcare overuse, intensive care, stepped-wedge
National Category
Health Care Service and Management, Health Policy and Services and Health Economy Anesthesiology and Intensive Care
Identifiers
urn:nbn:se:uu:diva-601041 (URN)10.1111/aas.70339 (DOI)001882977500001 ()42778513 (PubMedID)2-s2.0-105051459562 (Scopus ID)
Available from: 2026-10-16 Created: 2026-10-16 Last updated: 2026-10-16Bibliographically approved
Milerad, N., Ohman, C. A., Froding, I., Giske, C. G. & Castegren, M. (2025). Contact precautions prevent cross-contamination of extended-spectrum beta-lactamase-producing Enterobacterales in an intensive care unit: a prospective observational study. Annals of Intensive Care, 15(1), Article ID 193.
Open this publication in new window or tab >>Contact precautions prevent cross-contamination of extended-spectrum beta-lactamase-producing Enterobacterales in an intensive care unit: a prospective observational study
Show others...
2025 (English)In: Annals of Intensive Care, E-ISSN 2110-5820, Vol. 15, no 1, article id 193Article in journal (Refereed) Published
Abstract [en]

Background: The spread of multidrug-resistant microorganisms (MDROs), including extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-E), has increased worldwide and constitutes a significant public health challenge. International guidelines vary in their recommendations for isolation in single rooms and contact precautions regarding carriers of MDR microorganisms to mitigate cross-contamination in the ICU. The aim of this study was to investigate whether contact precautions without single-room isolation prevent cross-contamination of ESBL-E in an intensive care unit (ICU).

Methods: All patients admitted to a general ICU during a period of 19 months were included. The study began before the COVID-19 pandemic and continued, albeit interrupted during the first wave, through the second and third wave. Rectal swabs, swabs from drainages and intravenous catheters were sampled for the detection of ESBL-E in all patients at the time of admission. Swabs were also taken from all patients co-treated with an ESBL-E-positive patient (i.e., the index patient) at the time of discharge. All cross-contaminated patient bacterial isolates were analyzed with whole-genome sequencing and compared to the isolate from the corresponding index patient.

Results: Of 1042 patients admitted to the ICU, 82 patients were index patients, either known ESBL-carriers or tested positive at admission. 365 ESBL-E-negative patients (n=365) at ICU admission were co-treated in the same room as an index patient during their ICU-stay. Post-ICU discharge, three patients from the latter group tested positive for ESBL-E. No bacterial ESBLisolates from the latter patients corresponded to those of the index patients when their bacterial genomes were identified and compared.

Conclusions: Contact precautions without single-room isolation of ESBL-E-positive patients did not result in any cross-contamination between ICU-patients in an endemic setting with a short length of stay.

Place, publisher, year, edition, pages
Springer Nature, 2025
Keywords
Single room, Contact precautions, Extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-E), Intensive care unit (ICU)
National Category
Infectious Medicine Anesthesiology and Intensive Care
Identifiers
urn:nbn:se:uu:diva-574648 (URN)10.1186/s13613-025-01589-y (DOI)001634545500002 ()41372670 (PubMedID)
Available from: 2026-01-08 Created: 2026-01-08 Last updated: 2026-01-08Bibliographically approved
Bentzer, P., Lindén, A., Olsen, M. H., Lilja, G., Fisher, J., Sjövall, F., . . . Jakobsen, J. C. (2025). Protocolized REDUction of Non‐Resuscitation Fluids in SEptic Shock Patients: A Protocol for the REDUSE Randomized Clinical Trial. Acta Anaesthesiologica Scandinavica, 69(7), Article ID e70095.
Open this publication in new window or tab >>Protocolized REDUction of Non‐Resuscitation Fluids in SEptic Shock Patients: A Protocol for the REDUSE Randomized Clinical Trial
Show others...
2025 (English)In: Acta Anaesthesiologica Scandinavica, ISSN 0001-5172, E-ISSN 1399-6576, Vol. 69, no 7, article id e70095Article in journal (Refereed) Published
Abstract [en]

In septic shock, administration of large fluid volumes is associated with poor outcomes. Recent evidence shows that non-resuscitation fluids are the major modifiable source of fluids for patients with septic shock in intensive care units (ICUs). This clinical trial is designed to test the hypothesis that restrictive administration of non-resuscitation fluids improves outcomes compared to usual care. Adult patients admitted to ICUs with septic shock will be randomly assigned within 12 h of admission to receive protocolized restrictive administration of non-resuscitation fluids or usual care. The primary outcome is all-cause mortality at 90 days. Secondary outcomes are complications during ICU stay up to 90 days (defined as any acute kidney injury or cerebral, coronary, intestinal, or limb ischemia), mechanical ventilation free days within 90 days, and for survivors cognitive function (by the Montreal Cognitive Assessment [MOCA-BLIND]) and Health-Related Quality of Life (by the EQ Visual Analogue Scale [EQ-VAS]), both at 6 months. In addition, the climate impact of the interventions will be assessed. To detect an absolute reduction in mortality of 7.5%, with an alpha of 5% and a power of 90%, we aim to include 1850 patients. The trial is approved by the Swedish Ethical Review Authority. Results of primary and secondary clinical outcomes and the environmental outcome will be submitted for publication in a peer-reviewed journal.

Trial Registration: NCT06140147.

Place, publisher, year, edition, pages
John Wiley & Sons, 2025
National Category
Anesthesiology and Intensive Care
Identifiers
urn:nbn:se:uu:diva-566587 (URN)10.1111/aas.70095 (DOI)001535067500005 ()40671283 (PubMedID)2-s2.0-105011100273 (Scopus ID)
Funder
Region Skåne
Available from: 2025-09-05 Created: 2025-09-05 Last updated: 2025-10-30Bibliographically approved
Wilske, F., Eriksson, O., Amini, R.-M., Estrada, S., Janols, H., Khalil, A., . . . Antoni, G. (2025). Repeated positron emission tomography tracing neutrophil elastase in a porcine intensive-care sepsis model. Intensive Care Medicine Experimental, 13(1), Article ID 14.
Open this publication in new window or tab >>Repeated positron emission tomography tracing neutrophil elastase in a porcine intensive-care sepsis model
Show others...
2025 (English)In: Intensive Care Medicine Experimental, E-ISSN 2197-425X, Vol. 13, no 1, article id 14Article in journal (Refereed) Published
Abstract [en]

BACKGROUND: Neutrophil granulocytes are important parts of the defence against bacterial infections. Their action is a two-edged sword, the mediators killing the intruding bacteria are at the same time causing tissue damage. Neutrophil activation is part of the dysregulated immune response to infection defining sepsis and neutrophil elastase is one of the powerful proteases causing both effects and damage. Inhibition of neutrophil elastase has been tried in sepsis and ARDS, so far with inconclusive results.

METHODS: We used positron emission tomography (PET) combined with computed tomography (CT) and the selective and specific neutrophil elastase inhibitor PET-tracer [11C]GW457427 ([11C]NES), in an intensive care unit porcine Escherichia coli sepsis model with the primary aim to visualise the biodistribution of neutrophil elastase in the initial acute phase of the septic reaction. Repeated PET-CT investigations were performed before and after induction of sepsis.

RESULTS: At baseline [11C]NES uptake was found in the bone marrow, spleen and liver. The uptake in the bone marrow was markedly increased two hours into the sepsis, whereas in spleen and liver the uptake was not as markedly changed compared to baseline. At 4 h after the sepsis induction [11C]NES in the bone marrow decreased while the uptake increased in the spleen, liver and lungs.

CONCLUSION: The neutrophil elastase PET-tracer [11C]NES is a novel and unique instrument to study the acute innate neutrophil immune response in sepsis and associated vital organ failure. We here present images and quantitative data of the neutrophil elastase distribution the first hours of acute experimental sepsis. Surprisingly, a pronounced increase of neutrophil elastase was found in the bone marrow 2 h into the sepsis reaction followed at 4 h by increase in the liver, spleen and lungs and a concomitant reduction of the tracer uptake in bone marrow.

Place, publisher, year, edition, pages
Springer, 2025
Keywords
E coli, Neutrophil elastase, PET, Porcine, Sepsis, [11C]GW457427, [11C]NES
National Category
Infectious Medicine
Identifiers
urn:nbn:se:uu:diva-549773 (URN)10.1186/s40635-025-00721-3 (DOI)001414264600001 ()39904820 (PubMedID)
Funder
Stiftelsen Familjen Olinder-Nielsens fond för infektionsmedicinsk forskningSwedish Research Council, 2020–02312Ernfors FoundationEXODIAB - Excellence of Diabetes Research in SwedenP.O. Zetterling FoundationSwedish Child Diabetes FoundationDiabetesfondenInsamlingsstiftelsen Diabetes Wellness, 2409‑PG
Available from: 2025-02-07 Created: 2025-02-07 Last updated: 2025-02-28Bibliographically approved
Castegren, M. (2024). Så hanterade Region Sörmland covid-19-pandemin 2020–2021. Läkartidningen, 121, Article ID 23199.
Open this publication in new window or tab >>Så hanterade Region Sörmland covid-19-pandemin 2020–2021
2024 (Swedish)In: Läkartidningen, ISSN 0023-7205, E-ISSN 1652-7518, Vol. 121, article id 23199Article in journal (Refereed) Published
Abstract [en]

In Region Sörmland, the burden of critical illness during the first wave of Covid-19 in april 2020 lead to a 25-fold increase in the number of patients requiring invasive mechanical ventilation. The decision was made that quantity should be prioritised before individual quality. This led to a highly standardised care during the intensive care period. All patients admitted to any of the county's three hospitals were assessed as regarded their ability to survive invasive mechanical ventilation. The assessment was based on the Charlson Age-adjusted Comorbidity Index and the Clinical Frailty Scale. Of all >2000 admitted patients with Covid-19, 37% were assessed as not to benifit from mechanical ventilation. The outcome of intensive care patients was very good in Region Sörmland compared to the rest of Sweden, with a 30-day mortality rate of 14% following intensive care. The outcome after Covid-19-associated intensive care in Sweden differed highly between ICUs, with a span of 7-58% 30-day mortality rate.

Place, publisher, year, edition, pages
Läkartidningen Förlag AB, 2024
National Category
Infectious Medicine
Identifiers
urn:nbn:se:uu:diva-544406 (URN)39291580 (PubMedID)2-s2.0-85204512292 (Scopus ID)
Note

Title in PubMed: How Region Sörmland dealt with Covid-19 in 2020-2021

Available from: 2024-12-04 Created: 2024-12-04 Last updated: 2026-02-19Bibliographically approved
Krifors, A., Lignell, A., Lipcsey, M., Sjölin, J. & Castegren, M. (2023). An experimental porcine model of invasive candidiasis. Intensive Care Medicine Experimental, 11(1), Article ID 27.
Open this publication in new window or tab >>An experimental porcine model of invasive candidiasis
Show others...
2023 (English)In: Intensive Care Medicine Experimental, E-ISSN 2197-425X, Vol. 11, no 1, article id 27Article in journal (Refereed) Published
Abstract [en]

Background

Invasive candidiasis (IC) is a severe and often fatal fungal infection that affects critically ill patients. The development of animal models that mimic human disease is essential for advancing our understanding of IC pathophysiology and testing experimental or novel treatments. We aimed to develop a large animal model of IC that could provide a much-needed addition to the widely used murine models.

Results

A total of 25 pigs (including one control), aged between 9 and 12 weeks, with a median weight of 25.1 kg (IQR 24.1–26.2), were used to develop the porcine IC model. We present the setup, the results of the experiments, and the justification for the changes made to the model. The experiments were conducted in an intensive care setting, using clinically relevant anaesthesia, monitoring and interventions. The final model used corticosteroids, repeated Candida inoculation, and continuous endotoxin. The model consistently demonstrated quantifiable growth of Candida in blood and organs. The registered physiological data supported the development of the sepsis-induced circulatory distress observed in IC patients in the ICU.

Conclusions

Our proposed porcine model of IC offers a potential new tool in the research of IC.

Place, publisher, year, edition, pages
Springer Nature, 2023
National Category
Anesthesiology and Intensive Care Microbiology in the medical area
Identifiers
urn:nbn:se:uu:diva-503101 (URN)10.1186/s40635-023-00514-6 (DOI)000986487200001 ()37183195 (PubMedID)
Funder
Karolinska Institute
Available from: 2023-06-08 Created: 2023-06-08 Last updated: 2026-08-24Bibliographically approved
Göras, C., Lohela Karlsson, M., Castegren, M., Condén Mellgren, E., Ekstedt, M. & Bjurling-Sjöberg, P. (2023). From Threatening Chaos to Temporary Order through a Complex Process of Adaptation: A Grounded Theory Study of the Escalation of Intensive Care during the COVID-19 Pandemic. International Journal of Environmental Research and Public Health, 20(21), Article ID 7019.
Open this publication in new window or tab >>From Threatening Chaos to Temporary Order through a Complex Process of Adaptation: A Grounded Theory Study of the Escalation of Intensive Care during the COVID-19 Pandemic
Show others...
2023 (English)In: International Journal of Environmental Research and Public Health, ISSN 1661-7827, E-ISSN 1660-4601, Vol. 20, no 21, article id 7019Article in journal (Refereed) Published
Abstract [en]

To ensure high-quality care, operationalize resilience and fill the knowledge gap regarding how to improve the prerequisites for resilient performance, it is necessary to understand how adaptive capacity unfolds in practice. The main aim of this research was to explain the escalation process of intensive care during the first wave of the pandemic from a microlevel perspective, including expressions of resilient performance, intervening conditions at the micro-meso-macrolevels and short- and long-term consequences. A secondary aim was to provide recommendations regarding how to optimize the prerequisites for resilient performance in intensive care. A grounded theory methodology was used. First-person stories from different healthcare professionals (n70) in two Swedish regions were analyzed using the constant comparative method. This resulted in a novel conceptual model (including 6 main categories and 24 subcategories), and 41 recommendations. The conclusion of these findings is that the escalation of intensive care can be conceptualized as a transition from threatening chaos to temporary order through a complex process of adaptation. To prepare for the future, the components of space, stuff, staff, system and science, with associated continuity plans, must be implemented, anchored and communicated to actors at all levels of the system.

Place, publisher, year, edition, pages
MDPI, 2023
Keywords
COVID-19, adaptive capacity, grounded theory, healthcare, intensive care, resilience, resilient performance, surge response, unexpected crises
National Category
Public Health, Global Health and Social Medicine Anesthesiology and Intensive Care Nursing
Identifiers
urn:nbn:se:uu:diva-517174 (URN)10.3390/ijerph20217019 (DOI)37947575 (PubMedID)2-s2.0-85176408898 (Scopus ID)
Funder
Uppsala University, DLL-940876Sjukvårdsregionala forskningsrådet Mellansverige, RFR-939378Region Kalmar länRegion VästmanlandRegion SörmlandRegion DalarnaDalarna University
Available from: 2023-12-04 Created: 2023-12-04 Last updated: 2025-02-20Bibliographically approved
Schell, C. O., Wellhagen, A., Lipcsey, M., Kurland, L., Bjurling-Sjöberg, P., Stålsby Lundborg, C., . . . Baker, T. (2023). The burden of critical illness among adults in a Swedish region-a population-based point-prevalence study. European Journal of Medical Research, 28(1), Article ID 322.
Open this publication in new window or tab >>The burden of critical illness among adults in a Swedish region-a population-based point-prevalence study
Show others...
2023 (English)In: European Journal of Medical Research, ISSN 0949-2321, E-ISSN 2047-783X, Vol. 28, no 1, article id 322Article in journal (Refereed) Published
Abstract [en]

BACKGROUND: Patients with critical illness have a high risk of mortality. Key decision-making in the health system affecting the outcomes of critically ill patients requires epidemiological evidence, but the burden of critical illness is largely unknown. This study aimed to estimate the prevalence of critical illness in a Swedish region. Secondary objectives were to estimate the proportion of hospital inpatients who are critically ill and to describe the in-hospital location of critically ill patients.

METHODS: A prospective, multi-center, population-based, point-prevalence study on specific days in 2017-2018. All adult (> 18 years) in-patients, regardless of admitting specially, in all acute hospitals in Sörmland, and the patients from Sörmland who had been referred to university hospitals, were included. Patients in the operating theatres, with a psychiatric cause of admission, women in active labor and moribund patients, were excluded. All participants were examined by trained data collectors. Critical illness was defined as "a state of ill health with vital organ dysfunction, a high risk of imminent death if care is not provided and a potential for reversibility". The presence of one or more severely deranged vital signs was used to classify critical illness. The prevalence of critical illness was calculated as the number of critically ill patients divided by the number of adults in the region.

RESULTS: A total of 1269 patients were included in the study. Median age was 74 years and 50% of patients were female. Critical illness was present in 133 patients, resulting in an adult population prevalence of critical illness per 100,000 people of 19.4 (95% CI 16.4-23.0). The proportion of patients in hospital who were critically ill was 10.5% (95% CI 8.8-12.3%). Among the critically ill, 125 [95% CI 94.0% (88.4-97.0%)] were cared for in general wards.

CONCLUSIONS: The prevalence of critical illness was higher than previous, indirect estimates. One in ten hospitalized patients were critically ill, the large majority of which were cared for in general wards. This suggests a hidden burden of critical illness of potential public health, health system and hospital management significance.

Place, publisher, year, edition, pages
BioMed Central (BMC), 2023
National Category
Nursing
Identifiers
urn:nbn:se:uu:diva-513110 (URN)10.1186/s40001-023-01279-0 (DOI)001064985300003 ()37679836 (PubMedID)
Available from: 2023-10-03 Created: 2023-10-03 Last updated: 2023-12-21Bibliographically approved
Sadeghi, B., Ringdén, O., Gustafsson, B. & Castegren, M. (2022). Mesenchymal stromal cells as treatment for acute respiratory distress syndrome. Case Reports following hematopoietic cell transplantation and a review. Frontiers in Immunology, 13, Article ID 963445.
Open this publication in new window or tab >>Mesenchymal stromal cells as treatment for acute respiratory distress syndrome. Case Reports following hematopoietic cell transplantation and a review
2022 (English)In: Frontiers in Immunology, E-ISSN 1664-3224, Vol. 13, article id 963445Article in journal (Refereed) Published
Abstract [en]

Acute respiratory distress syndrome (ARDS) is a life-threatening lung disease. It may occur during the pancytopenia phase following allogeneic hematopoietic cell transplantation (HCT). ARDS is rare following HCT. Mesenchymal stromal cells (MSCs) have strong anti-inflammatory effect and first home to the lung following intravenous infusion. MSCs are safe to infuse and have almost no side effects. During the Covid-19 pandemic many patients died from ARDS. Subsequently MSCs were evaluated as a therapy for Covid-19 induced ARDS. We report three patients, who were treated with MSCs for ARDS following HCT. Two were treated with MSCs derived from the bone marrow (BM). The third patient was treated with MSCs obtained from the placenta, so-called decidua stromal cells (DSCs). In the first patient, the pulmonary infiltrates cleared after infusion of BM-MSCs, but he died from multiorgan failure. The second patient treated with BM-MSCs died of aspergillus infection. The patient treated with DSCs had a dramatic response and survived. He is alive after 7 years with a Karnofsky score of 100%. We also reviewed experimental and clinical studies using MSCs or DSCs for ARDS. Several positive reports are using MSCs for sepsis and ARDS in experimental animals. In man, two prospective randomized placebo-controlled studies used adipose and BM-MSCs, respectively. No difference in outcome was seen compared to placebo. Some pilot studies used MSCs for Covid-19 ARDS. Positive results were achieved using umbilical cord and DSCs however, optimal source of MSCs remains to be elucidated using randomized trials.

Place, publisher, year, edition, pages
Frontiers Media S.A., 2022
Keywords
mesenchymal stromal cells (MSCs), decidua stromal cells (DSCs), hematopoietic cell transplantation, acute respiratory distress syndrome (ARDS), cell therapy
National Category
Hematology Immunology
Identifiers
urn:nbn:se:uu:diva-491738 (URN)10.3389/fimmu.2022.963445 (DOI)000889655100001 ()36426365 (PubMedID)
Funder
Swedish Cancer Society, CAN 2018, 419Karolinska InstituteThe Cancer Society in Stockholm, 111293Swedish Childhood Cancer Foundation, PR2020-0058
Available from: 2023-01-03 Created: 2023-01-03 Last updated: 2024-01-17Bibliographically approved
Organisations
Identifiers
ORCID iD: ORCID iD iconorcid.org/0000-0002-9292-0298

Search in DiVA

Show all publications